Puma Biotechnology Inc.

NASDAQ: PBYI · Real-Time Price · USD
5.07
0.07 (1.30%)
At close: Aug 19, 2025, 3:59 PM
5.05
-0.39%
Pre-market: Aug 20, 2025, 08:17 AM EDT

Puma Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
5.86M 2.97M 19.3M 20.32M -4.53M -4.82M 12.27M 5.8M 2.13M 1.4M -5.61M -360K 9.37M -3.4M 4.22M -44.67M -5.21M 16.53M
Depreciation & Amortization
2.76M 2.8M 2.84M 2.88M 2.91M 2.9M 2.89M 2.88M 2.88M 2.88M 2.21M 2.23M 2.46M 2.26M 2.27M 2.44M 2.94M 2.95M
Stock-Based Compensation
1.63M 2.03M 1.75M 2.05M 2.06M 2.38M 2.43M 2.54M 2.43M 2.84M 2.63M 2.83M 3.22M 3.15M 4.25M 4.28M 18.24M 5.86M
Other Working Capital
5.02M -11.51M -15.8M 11.94M 1.52M -14.52M 11.3M -2.76M 522K -16.44M 21.34M 306K -237K -30.46M 1.32M 24.26M -12.29M -3.35M
Other Non-Cash Items
-362K 213K -398K -48K -183K 110K 27.38M -1.79M -1.66M -3.38M 7M -4.97M 2.43M 1K 1K 8.15M -1M 18.09M
Deferred Income Tax
n/a n/a -7.08M n/a n/a n/a -27.01M 2.42M 2.18M 3.38M n/a 4.97M n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.2M -4.4M -818K -14.16M 769K 10.68M -7.5M -1.23M -4.65M -4.47M 1.45M 12.56M -28.93M -28.9M -16.18M 40.3M -15.04M -9.68M
Operating Cash Flow
14.08M 3.61M 15.61M 11.04M 1.03M 11.25M 10.46M 10.62M 3.3M 2.64M 7.68M 17.26M -13.87M -26.89M -5.43M 10.5M -74K 15.66M
Capital Expenditures
-20K -61K -16K -20K -20K n/a -45K -27K -68K -12.5M -7M n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 8.13M -11.21M 68K n/a 7M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-21.91M -12.51M -15.27M -16.06M -19.92M -24.97M -11.3M -1.97M -5.59M -4.95M -4.84M n/a n/a n/a n/a -18.96M -8.42M -10.7M
Sales Maturities Of Investments
10.69M 14.1M 12.97M 16.34M 20.64M 5.89M 3.18M 13.17M 978K n/a -37K 8M 2M 8.98M 4.62M 14.49M 2.69M 5.39M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -8.13M 11.21M -68K -17.45M -7M 8M 2M 8.98M 4.62M -4.47M -5.73M -5.3M
Investing Cash Flow
-11.25M 1.53M -2.32M 259K 703K -19.08M -8.17M 11.18M -4.68M -17.45M -11.87M 8M 2M 8.98M 4.62M -4.47M -5.73M -5.3M
Debt Repayment
-11.11M -11.11M -11.11M -11.11M -11.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.5M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-92K -222K -221K -223K -222K n/a n/a n/a n/a n/a -69K -53K n/a -155K -2K -30.43M n/a n/a
Financial Cash Flow
-11.2M -11.33M -11.33M -11.18M -11.33M n/a n/a n/a n/a n/a 2.43M -53K n/a 9.85M -2K -31.93M n/a n/a
Net Cash Flow
-8.37M -6.19M 1.96M 114K -9.6M -7.83M 2.29M 21.79M -1.39M -14.81M -1.76M 25.2M -11.88M -8.07M -816K -25.9M -5.8M 10.36M
Free Cash Flow
14.06M 3.55M 15.59M 11.02M 1.01M 11.25M 10.41M 10.59M 3.23M -9.86M 683K 17.26M -13.87M -26.89M -5.43M 10.5M -74K 15.66M